A major part of our mission is to fund and promote medical research on Hutchinson-Gilford Progeria Syndrome in order to accomplish our goal of developing treatments and a cure. PRF awards research grants (23 as of December 2007!) through peer review by our volunteer Medical Research Committee. Awards of up to $50,000, for up to two years, have allowed innovative new research in Progeria to thrive. PRF has also organized four successful scientific conferences that have brought together scientists and clinicians from all over the world to collaborate, sharing their ideas and contributing their expertise in this lethal disease. And the number of peer-reviewed, scientific publications on Progeria research has soared, a reflection of the ever-increasing interest by researchers in this field, thanks in large part to PRF’s efforts.

Click here to see the Progeria Publications and Abstracts

Researchers have recently published studies that support a potential drug treatment for children with Progeria; Farnesyltransferase inhibitors (FTIs).

Here are some answers to Frequently Asked Questions about FTI's